Breakthrough in migraine therapy
New anti-migraine drugs that have fewer side effects than existing treatments could be on the market within three years, scientists said yesterday.
They have been developed thanks to improved understanding of the mechanism that makes the brain over-react to stimuli and will usher in a new era in management of the condition, experts say.
Migraine is a hereditary illness which affects an estimated six million Britons – or 15 per cent of all adults. It is caused by an "oversensitive" brain which reacts to triggers such as fatigue, hunger, stress or the weather with a throbbing, one-sided headache, often accompanied by nausea and visual disturbances. Three times more women than men are sufferers.
One of the new drugs – a rescue treatment known only by its code MK0974 – interrupts the sequence of chemical reactions in the brain that cause a migraine at a different point from existing drugs.
Studies have shown that the brain releases the chemical calcitonin gene-related peptide (CGRP) during a migraine. Existing drugs, called triptans, block the release of the chemical. The new drug, known as a CGRP antagonist, blocks uptake of the chemical by neighbouring nerve cells.
Final trial results to be presented later this month to the American Headache Society will show that MK0974 reduces pain and is better at preventing the return of the migraine over 24 hours than existing triptan drugs, of which the best known is sumatriptan.
Peter Goadsby, leader of the headache group at the Institute of Neurology, University College London, said yesterday: "[MK0974] is very well tolerated and does really well compared with current treatments. It is going to be an important advance. We are well on the way to having a totally novel way of treating migraine."
Life & Style blogs
Half of young women unable to ‘locate vagina’ and 65% find it difficult to say the word
Is Apple's iCloud safe after leak of Jennifer Lawrence and other celebrities' nude photos?
Porn film production 'must stop in Los Angeles' after actor tests positive for HIV
Anal sex study reveals climate of 'coercion'
The science of saturated fat: A big fat surprise about nutrition?
- 1 Half of young women unable to ‘locate vagina’ and 65% find it difficult to say the word
- 2 Perez Hilton apologises for Jennifer Lawrence naked photo leak
- 3 A teacher speaks out: 'I'm effectively being forced out of a career that I wanted to love'
- 4 Mexican woman becomes world’s 'oldest person' at 127
- 5 Jennifer Lawrence 'naked sex video' will be leaked threatens 4Chan celebrity photo hacker
£40000 - £50000 per annum + benefits+bonus+package: Harrington Starr: SQL Impl...
£45000 - £55000 per annum + Benefits + Bonus: Harrington Starr: SQL Technical ...
£85000 per annum: Harrington Starr: Head of IT (Windows, Server, VMware, SAN, ...
£55000 - £60000 per annum + Benefits + Bonus: Harrington Starr: Lead C# Develo...